Ghrelin, an endogenous ligand for the growth hormone (GH) secretagogue receptor, was originally purified from rat stomach; subsequently, ghrelin neurons were found in the arcuate nuclei of rats. Central effects of the peptide on GH release, however, remain to be clarified. The aim of the present study was to determine the morphologic features of GH-producing pituicytes and serum GH concentration after central administration of ghrelin. Five injections of rat ghrelin or phosphate-buffered saline (PBS; n = 10 rats/group) were given every 24 hrs (1 μg of ghrelin in 5 μl of PBS) into the lateral cerebral ventricle of male rats. Significant (P < 0.05) increases in absolute and relative pituitary weights occurred in ghrelin-treated rats versus controls (58% and 41%, respectively). Morphometric parameters (i.e., the volume of GH cells, volume of their nuclei, and volume density) all significantly (P < 0.05) increased by 17%, 18%, and 19%, respectively, in the ghrelin-treated group versus controls. Terminal serum concentration of GH was significantly (P < 0.05) increased by 15% with ghrelin treatment. The results clearly document that daily nanomolar doses of ghrelin into the lateral cerebral ventricle stimulate GH cell proliferation and promote GH release. Thus, achieving pharmacologic control of central ghrelin receptors is a promising modality to modulate the actions of GH.
MilosevicV, BrkicB, VelkovskiSD, SekulicM, LovrenM, StarcevicV, SeversWB. Morphometric and functional changes of rat pituitary somatotropes and lactotropes after central administration of somatostatin. Pharmacology57: 28–34, 1998.
2.
BowersCY, MomanuF, ReynoldsGA, ChangD, HongA, ChangK.Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology106: 663–667, 1980.
3.
BowersCY, MomanuF, ReynoldsGA, ChangD, HongA.On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology114: 1537–1545, 1984.
4.
BowersCY, ReynoldsGA, DurhamD, BarreraCM, PezzoliSS, ThornerMO. Growth hormone (GH)–releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab70: 975–982, 1990.
KojimaM, HosodaH, DateY, NakazatoM, MatsuoH, KangawaK.Ghrelin is a growth hormone releasing acylated peptide from stomach. Nature402: 656–660, 1999.
7.
KorbonitsM, GoldstoneAP, GueorguievM, GrossmanAB. Ghrelin—a hormone with multiple functions. Front Neuroendocrinol25: 27–68, 2004.
8.
TamuraH, KamegaiJ, ShimizuT, IshiiS, SugiharaH, OikawaS.Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats. Endocrinology143: 3268–3275, 2002.
9.
DateY, MurakamiN, KojimaM, KuroiwaT, MatsukuraS, KangowaK, NakazatoM.Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem Biophys Res Commun275: 477–480, 2000.
10.
SeoaneLM, TovarL, BaldelliR, ArvatE, GhigoE, CasanuevaFF, DiguezC.Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. Eur J Endocrinol14:R7–R9, 2000.
11.
TolleV, ZizzariP, TomasettoC, RioMC, EpelbaumJ, Bluet-PajotMT. In vivo and in vitro effects of ghrelin/motilin-related peptide on growth hormone secretion in rat. Neuroendocrinology73: 54–61, 2001.
12.
StarčevićVP, MorrowBA, FamerLA, KeilLC, SeversWB. Long-term recording of cerebrospinal fluid pressure in freely behaving rats. Brain Res462: 112–117, 1988.
13.
KamegaiJ, TamuraH, ShimizuT, IshiiS, SugiharaH, WakabayashiI.Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes50: 2438–2443, 2001.
14.
StembergerLA, HardyPHJ, CuculiusJJ, MeyerHG. The unlabelled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem18: 315–333, 1970.
BailyART, GilesME, BrownCH, BullPM, MacDonaldLP, SmithLC, SmithRG, LengG, DicksonSL. Chronic central infusion of growth hormone secretagogues: effects on fos expression and peptide gene expression in the rat arcuate nucleus. Neuroendocrinology70: 83–92, 1999.
19.
ThompsonNM, DaviesJS, ModeA, HoustonPA, WellsT.Pattern-dependent suppression of growth hormone pulsatility by ghrelin and GHRP-6 in moderately GH-deficient rats. Endocrinology144: 4859–4867, 2003.
20.
MuccioliG, TschopM, Papotti, DeghengniR, HeimanM, GhigoE.Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol440: 235–254, 2002.
SunY, WangP, ZhengH, SmithRG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A101: 4679–4684, 2004.
26.
TolleV, BassantMH, ZizzariP.Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology143: 1353–1361, 2002.
27.
TolleV, KadernM, Bluet-PajotMT, FrereD, FoulonC, BossuC, DardennesR, MounierC, ZizzariP, LangF, EpelbaumJ, EstourB.Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab88: 109–116, 2003.
28.
TannenbaumGS, EpelbaumJ, BowersCY. 2003. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone–releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology144: 967–974, 2003.
29.
OsbornBL, AbramsonFP. Pharmacokinetic and metabolism studies using uniformly stable isotope-labelled proteins with HPLC/CRIMS detection. Biopharm Drug Dispos19: 439–444, 1998.
30.
KingPJ. The hypothalamus and obesity. Current Drug Targets6: 225–240, 2005.
31.
CummingsDE, Foster-SchubertKE, OverduinJ.Ghrelin and energy balance: focus on current controversies. Current Drug Targets6: 153–169, 2005.
